Table 1 Clinicopathological analysis.

From: Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

Cohort

Total (N)

Positive (%)

Negative (%)

P-value

Age

0.647

<=55

18

33

67

 

>55

28

29

71

 

Grade

   

<0.0001***

I

19

32

68

 

II

24

25

75

 

III

3

67

33

 

Lymph Node Metastasis

<0.0001***

0

28

36

64

 

1

6

0

100

 

2

4

75

25

 

3

3

0

100

 

MKI67

<0.008**

Low

10

20

80

 

Moderate

21

29

71

 

Strong

15

40

60

 
  1. *P < 0.05, **P < 0.01, and ***P < 0.001.
  2. Correlation analysis between pBADSer99/BAD ratio and clinicopathological features of TNBC patient. 
Back to article page